Company intelligence / Profile preview

RC Bioform

Moscow, Russia

Ownership: Private
Development stage: Other

Overview

RC Bioform manufactures sterile hydrogels and polymer-based injectable devices, such as NOLTREX for synovial fluid supplementation, used in osteoarthritis and related conditions. Clinical studies and commercial data indicate efficacy in joint lubrication and minimally invasive surgery support. Products are approved and in use in Russia and other markets.[4]

Therapeutic areas: NephrologyRheumatologyGastroenterologyOtherDermatology
Modalities: Hydrogel-based medical devicePolyacrylamide gelBiopolymer
Industry: Therapeutic Medical Devices

Partnerships

Russian Scientific Center of Surgery n.a. B.V. Petrovsky of the Russian Academy of Medical SciencesCentral Research Institute of Dental and Maxillofacial SurgeryFirst Moscow State Medical University n.a. I.M. SechenovRussian Scientific Research Institute of Traumatology and Orthopedics n.a. R.R. Vreden

Beyond the preview

Go deeper on RC Bioform.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RC Bioform.

Explore the full profile